-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Endonovo Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
- Endonovo Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was 17.3 %, a 0.35% decline year-over-year.
- Endonovo Therapeutics, Inc. annual Return On Equity for 2022 was 83.1 %, a 348% increase from 2021.
- Endonovo Therapeutics, Inc. annual Return On Equity for 2021 was 18.6 %, a 491% increase from 2020.
- Endonovo Therapeutics, Inc. annual Return On Equity for 2020 was 3.14 %, a 97.1% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)